Needham Downgrades Cidara Therapeutics (CDTX) to Hold Nov 14, 2025 12:13PM
Cidara Therapeutics (CDTX) PT Raised to $36 at Needham Jun 4, 2025 07:12AM
Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference Apr 1, 2025 04:05PM
Cidara Therapeutics (CDTX) PT Raised to $25 at Needham Apr 25, 2024 07:29AM
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results May 11, 2023 04:37PM


Mar 31, 2023 08:00AM Cidara Therapeutics to Participate in Upcoming Investor Conferences
Jul 8, 2022 06:11AM Needham & Company Reiterates Buy Rating, $6 Price Target on Cidara Therapeutics (CDTX)
Mar 8, 2022 06:10AM Needham & Company Reiterates Buy Rating on Cidara Therapeutics (CDTX)
Oct 13, 2021 04:01PM Cidara Therapeutics Announces Closing of Concurrent Public Offerings of Common Stock and Preferred Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of
Oct 13, 2021 04:01PM Cidara Therapeutics Announces Closing of Concurrent Public Offerings of Common Stock and Preferred Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of
Oct 8, 2021 09:13AM Cidara Therapeutics (CDTX) Prices 14.84M Share Offering at $1.55/sh
Oct 8, 2021 09:12AM Cidara Therapeutics Announces Pricing of Concurrent Public Offerings of Common Stock and Preferred Stock
Oct 8, 2021 09:12AM Cidara Therapeutics Announces Pricing of Concurrent Public Offerings of Common Stock and Preferred Stock
May 13, 2021 04:29PM Cidara Provides Corporate Update and Reports First Quarter 2021 Financial Results
May 13, 2021 04:29PM Cidara Provides Corporate Update and Reports First Quarter 2021 Financial Results
Apr 7, 2021 08:00AM Cidara Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
Apr 7, 2021 08:00AM Cidara Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
May 13, 2020 04:52PM Cidara Provides Corporate Update and Reports First Quarter 2020 Financial Results
Apr 7, 2020 08:00AM Cidara Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
Mar 5, 2020 07:13AM Cidara Therapeutics (CDTX) PT Lowered to $6 at Needham & Company
Apr 3, 2019 04:04PM Cidara Therapeutics to Present at the 18th Annual Needham Healthcare Conference
Nov 9, 2017 07:48AM Cidara Therapeutics (CDTX): Expecting A Positive Rezafungin Phase 2 Outcome In 1Q - Needham
Apr 10, 2017 07:22AM Needham and Company Reiterates Buy Rating and $10 PT on Cidara Therapeutics (CTDX) Following Investor Day; 'Shares Attractive Ahead of Ph2 CD-101'
Feb 21, 2017 01:20PM Cidara Therapeutics (CDTX) PT Lowered to $10 at Needham & Company; Keeps 'Buy'
Aug 15, 2016 08:19AM Needham & Company Reiterates Buy on Cidara Therapeutics (CDTX) Following 2Q Report
Apr 5, 2016 07:30AM Cidara Therapeutics to Present at the Needham & Company 15th Annual Healthcare Conference
May 11, 2015 07:25AM Needham & Company Starts Cidara Therapeutics (CDTX) at Buy
Apr 15, 2015 10:50AM Cidara Therapeutics (CDTX) IPO Opens Flat
Apr 15, 2015 07:37AM Cidara Therapeutics (CDTX) IPO Prices at $16, Top End of Range
Apr 15, 2015 07:30AM Cidara Therapeutics Announces Pricing of Initial Public Offering